(a) The following shall be immune from civil or criminal liability for the performance of actions authorized by this subchapter; provided, that no immunity shall extend to gross negligence, recklessness, or intentional misconduct:
(1) An authorized entity and its employees or agents; and
(2) A third party that facilitates the availability of epinephrine auto-injectors to an authorized entity.
(b) The following shall be immune from civil or criminal liability for the performance of actions authorized by this subchapter; provided, that no immunity shall extend to gross negligence, recklessness, intentional misconduct, or a willful or wanton disregard for the health or safety of others:
(1) A health care professional that prescribes epinephrine auto-injectors to an authorized entity;
(2) A pharmacist that dispenses or distributes epinephrine auto-injectors to an authorized entity; and
(3) An organization, individual, or entity that conducts the training described in § 7-2381.04.
(Feb. 22, 2019, D.C. Law 22-207, § 7, 65 DCR 12365.)
Applicability of D.C. Law 22-207: § 7155 of D.C. Law 23-16 repealed § 10 of D.C. Law 22-207. Therefore the creation of this section by D.C. Law 22-207 has been implemented.
Applicability of D.C. Law 22-207: § 10 of D.C. Law 22-207 provided that the creation of this section by § 7 of D.C. Law 22-207 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.